


Searching News Database: Biocon
HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
HSMN NewsFeed - 13 Mar 2017
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
HSMN NewsFeed - 28 Jan 2014
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 14 Jun 2011
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
HSMN NewsFeed - 26 Apr 2011
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
HSMN NewsFeed - 21 Sep 2010
Bioconnect Systems Gains CE Mark Approval for Optiflow Anastomotic System
Bioconnect Systems Gains CE Mark Approval for Optiflow Anastomotic System
HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
HSMN NewsFeed - 20 Nov 2007
EarlySense Receives FDA Clearance for Its Contact-Free Patient's Clinical Status Monitor
EarlySense Receives FDA Clearance for Its Contact-Free Patient's Clinical Status Monitor
HSMN NewsFeed - 6 Nov 2007
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
HSMN NewsFeed - 17 Apr 2007
FDA Seizes All Medical Products From N.J. Device Manufacturer for Significant Manufacturing Violations
FDA Seizes All Medical Products From N.J. Device Manufacturer for Significant Manufacturing Violations
HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
HSMN NewsFeed - 14 Jul 2006
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
HSMN NewsFeed - 11 May 2006
ConjuChem Announces New Executive Vice President, Research and Development
ConjuChem Announces New Executive Vice President, Research and Development
Additional items found! 14
Members Archive contains
14 additional stories matching:
Biocon
(Password required)
Biocon
(Password required)
